drug · small molecule
CAL-101
Phase 2updated 6mo agoby Calluna Pharma AS🔗 ChEMBL
Phase 2community read0 votes
Small molecule drug with a maximum clinical stage of Approval (across all indications), with 5 approved and 10 investigational indications.
indications
indications
Pulmonary Fibrosis
targets
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform
all catalysts(0)
nothing on the calendar yet
Trials studying CAL-101
News(1)
- Merck KGaA spinout iOnctura touts PI3K delta inhibitor in metastatic eye canceriOnctura’s PI3K delta inhibitor shows promise in phase 1 study in patients with mostly pre-treated metastatic melanoma.fiercebiotech · 1mo ago
Data sources
last refreshed 3h ago
Found something off?
comments(0)
5-min edit window · permanent after that